Trump’s COVID-19 infection makes re-election uncertain
President Trump’s illness with coronavirus exposes an election soft spot that could cost him the Nov. 3, 2020 General election. Trump was treated by the newest antibiotic treatments that are not available to the general public. And, when he did get COVID-19, he didn’t turn to using hydroxychloroquine which he touted as a super drug to fight the virus. His illness also shifted the focus away from the fight against lawlessness associated with the looters and the Black Lives Matter protests gone wild
By Ray Hanania
Until the first debate, I was convinced that President Trump had a great chance of winning re-election. He is the incumbent, the victim of mainstream news media bias, and the public’s focus has been on the nation’s divisions, emotional anger and not the substantive issues.
The news media and his critics and foes have made this a personal assault against Trump, not one based on real issues.
That all changed after the debate when Trump and First Lady Melania Trump tested positive for COVID-19 and the President had to be taken to Walter Reed Medical National Military Medical Center.
Why did he get it? Like many conservatives, Trump thinks wearing a facemask is a violation of his Constitutional rights.
SUBSCRIBE TO RAY HANANIA'S COLUMN
=======================================
President Donald J. Trump and Ivanka Trump | June 13, 2017 (Photo courtesy of the White House. Official White House Photo by Joyce N. Boghosian)
Instead of strongly encouraging people to wear a face mask – it’s better to be safe than sorry – he sent a clear message that face masks don’t work, even poking fun at Democratic rival Joe Biden during the debate for wearing a face mask “everywhere.”
Trump engaged in lax social distancing, not wearing face masks while flaunting the “tough guy” sense of invincibility at public appearances.
That certainly makes him look like a poor leader in a way that supersedes the biased but similar attacks spearheaded by the national news media.
But the worst issue has always been the issue of “hypocrisy.” And until now, the issue of hypocrisy has weighed heaviest on the biased, one-sided partisan national news media. Instead of being professional journalists, they have been PR flaks for the Democratic Party and their nominee, Biden.
That changed when Trump became infected. Trump stole the issue of hypocrisy away from the Democrats and the national news media, wearing that collar in a way that makes him stand out in a very vulnerable way.
While hundreds of thousands of Americans are struggling with the COVID-19 virus, with no real treatment, we are told President Trump is being treated with two different experimental drugs that have not yet been approved for the rest of us.
Trump received a single dose of an experimental antibody cocktail being developed by the biotech company Regeneron, whose CEO has been Trump’s pal for years. And, Trump received another experimental antiviral drug called Remdesivir, made by Gilead Sciences.
The president was also being treated with several other drugs including zinc, vitamin D and a generic version of the heartburn treatment, Pepcid, his White House said on Friday after the president was taken to the hospital.
What about the rest of us?
Why aren’t these experimental drugs available to the public? Why isn’t the White House telling the public these treatments can be available to treat COVID-19 patients. Why aren’t pharmaceutical companies making them publicly available?
Some 200,000 Americans have died during the spread of this virus that began at a Chinese laboratory in Wuhan – a point we should not forget and address more forcefully with tough sanctions when the nation overcomes the virus completely. The United States should sue China and force them to pay for all of the financial losses caused by this experimental virus screw-up.
The United States owes China nearly $1.1 trillion dollars, our second largest mortgage holder next only to Japan which we owe about $1.26 trillion according to the U.S. Department of the Treasury.
But that’s something we need to pursue next year when the pandemic is defeated.
In the meantime, the American people, especially the viruses’ most vulnerable victims, seniors, should be asking why has the Trump administration withheld the experimental treatments until now? Why is it ok for Trump to get the drug, despite the FDA’s failure to approve it, but the rest of us have to suffer through the virus threat with nothing?
Trump, who looked tough and unphased prior to getting sick, now looks weak and, worse, ignorant or even selfish. His assertions we don’t need to wear face masks and his failure to enforce social distancing, as evidenced by his numerous public events and activities, only reinforces weak leadership.
His ability to get treatment using these experimental drug cocktails suggests government only cares about itself, not the public. Those who have been disappointed and critical of the failures of the Democrats on the national level now have to weigh that against saving their own lives.
Trump, and other politicians who ridicule wearing face masks, are irresponsible. It raises real issues about being fit to hold public office.
The health of the public should be the number one priority of our elected officials. How Trump is being treated raises a serious question about his administration’s lack of commitment to us.
(Originally published in the Southwest News Newspaper group including the Des Plaines Valley News and the The Regional Newspaper. For more of Ray Hanania’s columns, podcasts and radio shows visit www.Hanania.com.)
Hanania also writes about Middle East issues for the Arab News, and The Arab Daily News criticizing government policies in the Israeli-Palestinian conflict.
A critic of mainstream news media bias, Hanania advocates for peace & justice for Israel & Palestine, & the empowerment of Arabs in America.
Click here to listen to Ray's Political Podcast.
Hanania's columns are archived on his personal website at RayHanania.com. Hanania was named "Best Ethnic American Columnist" by the New America Media in November 2007, and is the 2009 recipient of the SPJ National Sigma Delta Chi Award for column writing.
Hanania is President/CEO of Urban Strategies Group which provides communications services to governments and private businesses, and hosts writing training workshops, and publishes books.
Email Ray Hanania at rghanania@gmail.com.
- California 50th and Illinois 3rd Congressional battles explored on Arab Radio - October 20, 2020
- Four Cook County Judges you should watch out for - October 19, 2020
- Nothing Fair about the so-called “Fair Tax” - October 18, 2020
